Background Patients with schizophrenia represent a vulnerable, underserved, and
undertreated population who have been neglected in health disparities work. Understanding …

Background Cancer patients with schizophrenia may face disparities in end-of life care, and
it is unclear whether schizophrenia affects their medical care and treatment. Methods We …

Objective: To compare place and cause of death for people with and without schizophrenia
in Manitoba, Canada. Method: By using deidentified administrative databases at the …

BackgroundHealthcare access and outcomes in cancer patients with schizophrenia remain
unclear. AimsTo investigate the likelihood of early diagnosis and treatment in patients with …

Individuals with schizophrenia are a vulnerable population that has been relatively
neglected in health disparities research. Despite having an equivalent risk of developing …

CONTEXT: The rate of health care and palliative care utilization for patients with
schizophrenia near the end-of-life is currently unknown. OBJECTIVE: Compare rate of …

BackgroundPrevious studies have reported conflicting results on the association between
schizophrenia and cancer mortality. AimsTo summarise available evidence and quantify the …

Objective Schizophrenia is associated with premature mortality, but the specific causes and
pathways are unclear. The authors used outpatient and inpatient data for a national …

BACKGROUND: Schizophrenia has been associated with a rate of premature mortality that
is 2 to 3 times higher than that in the general population. Although the role of cancer in this …

Aim: We conducted a matched-cohort study to assess mortality in schizophrenia and the
relationship of mortality with comorbid somatic conditions and suicide attempts. Method: A …